Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1465-542X
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer ; volume:22 ; number:1 ; day:30 ; month:11 ; year:2020 ; pages:1-13 ; date:12.2020
Breast cancer research ; 22, Heft 1 (30.11.2020), 1-13, 12.2020

Creator
Zoeller, Jason J.
Vagodny, Aleksandr
Daniels, Veerle W.
Taneja, Krishan
Tan, Benjamin Y.
DeRose, Yoko S.
Fujita, Maihi
Welm, Alana L.
Letai, Anthony
Leverson, Joel D.
Blot, Vincent
Bronson, Roderick T.
Dillon, Deborah A.
Brugge, Joan
Contributor
SpringerLink (Online service)

DOI
10.1186/s13058-020-01374-8
URN
urn:nbn:de:101:1-2021010907181211006879
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:34 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Zoeller, Jason J.
  • Vagodny, Aleksandr
  • Daniels, Veerle W.
  • Taneja, Krishan
  • Tan, Benjamin Y.
  • DeRose, Yoko S.
  • Fujita, Maihi
  • Welm, Alana L.
  • Letai, Anthony
  • Leverson, Joel D.
  • Blot, Vincent
  • Bronson, Roderick T.
  • Dillon, Deborah A.
  • Brugge, Joan
  • SpringerLink (Online service)

Other Objects (12)